Roberts Margo R
Chief Scientific Officer at Kite Pharma, Inc.
- Sold, on record
- $6.9M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Mar 15, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Kite Pharma, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Kite Pharma, Inc.UnusualSep 15 2015
Sold 6,145 shares at $64.33 ($395k)
Roberts Margo R, Chief Scientific Officer
Sold 73.7% of holdings ($537k position)2,198 shares left0.7x usual sizeFiling
- 2 Form 4 sale Kite Pharma, Inc.UnusualOct 15 +30 days
Sold 6,145 shares at $62.57 ($385k)
Roberts Margo R, Chief Scientific Officer
Sold 73.7% of holdings ($522k position)2,198 shares left0.7x usual sizeFiling
- 3 Form 4 sale Kite Pharma, Inc.UnusualNov 16 +32 days
Sold 6,145 shares at $78.16 ($480k)
Roberts Margo R, Chief Scientific Officer
Sold 73.7% of holdings ($652k position)2,198 shares left0.8x usual sizeFiling
- 4 Form 4 sale Kite Pharma, Inc.UnusualDec 15 +29 days
Sold 6,145 shares at $63.76 ($392k)
Roberts Margo R, Chief Scientific Officer
Sold 73.7% of holdings ($532k position)2,198 shares left1x usual sizeFiling
- 5 Form 4 sale Kite Pharma, Inc.UnusualJan 15 +31 days
Sold 6,145 shares at $55.22 ($339k)
Roberts Margo R, Chief Scientific Officer
Sold 40.3% of holdings ($842k position)9,098 shares left1x usual sizeFiling
- 6 Form 4 sale Kite Pharma, Inc.UnusualFeb 12 +28 days
Sold 18,750 shares at $64.16 ($1.2M)
Roberts Margo R, Chief Scientific Officer
Sold 67.3% of holdings ($1.8M position)9,098 shares left3.1x usual sizeFiling
- 7 Form 4 sale Kite Pharma, Inc.UnusualFeb 17 +5 days
Sold 9,632 shares at $45.06 ($434k)
Roberts Margo R, Chief Scientific Officer
Sold 51.4% of holdings ($844k position)9,098 shares left1.6x usual sizeFiling
- 8 Form 4 sale Kite Pharma, Inc.UnusualMar 15 +27 days
Sold 8,506 shares at $45.23 ($385k)
Roberts Margo R, Chief Scientific Officer
Sold 44.4% of holdings ($867k position)10,655 shares left1.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2016 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 8,506 | $385k | 44.4% | Unusual | SEC |
| Feb 17, 2016 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 9,632 | $434k | 51.4% | Unusual | SEC |
| Feb 12, 2016 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 18,750 | $1.2M | 67.3% | Unusual | SEC |
| Jan 15, 2016 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 6,145 | $339k | 40.3% | Unusual | SEC |
| Dec 15, 2015 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 6,145 | $392k | 73.7% | Unusual | SEC |
| Nov 16, 2015 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 6,145 | $480k | 73.7% | Unusual | SEC |
| Oct 15, 2015 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 6,145 | $385k | 73.7% | Unusual | SEC |
| Sep 15, 2015 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 6,145 | $395k | 73.7% | Unusual | SEC |
| Aug 17, 2015 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 6,145 | $374k | 86.0% | Unusual | SEC |
| Jul 15, 2015 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 22,167 | $1.6M | 95.7% | Unusual | SEC |
| Jun 15, 2015 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 8,625 | $491k | 89.6% | Unusual | SEC |
| May 15, 2015 | Kite Pharma, Inc. | Chief Scientific Officer | Form 4 sale | 8,625 | $433k | 89.6% | Unusual | SEC |